BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8276122)

  • 21. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.
    Antonelli A; Ferrari SM; Mancusi C; Mazzi V; Pupilli C; Centanni M; Ferri C; Ferrannini E; Fallahi P
    Immunobiology; 2013 May; 218(5):690-5. PubMed ID: 22944249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staurosporine induces the cell surface expression of both forms of human tumor necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response.
    Zhang L; Higuchi M; Totpal K; Chaturvedi MM; Aggarwal BB
    J Biol Chem; 1994 Apr; 269(14):10270-9. PubMed ID: 8144608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of mitogenic activity of tumor necrosis factor by interferons and dexamethasone.
    Tsujimoto M; Sugiyama M; Adachi H
    Lymphokine Res; 1989; 8(2):99-106. PubMed ID: 2499736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER; Mutch DG; Herzog TJ
    Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment.
    Wolber EM; Haase B; Jelkmann W
    J Interferon Cytokine Res; 2002 Dec; 22(12):1185-9. PubMed ID: 12581491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
    Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
    Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
    J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
    Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer.
    Wan L; Lin CW; Lin YJ; Sheu JJ; Chen BH; Liao CC; Tsai Y; Lin WY; Lai CH; Tsai FJ
    J Cell Mol Med; 2008 Jun; 12(3):876-88. PubMed ID: 18494930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response.
    Pocsik E; Mihalik R; Ali-Osman F; Aggarwal BB
    J Cell Biochem; 1994 Apr; 54(4):453-64. PubMed ID: 8014194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane oxidative metabolism of human eosinophilic cell line EoL-1 in response to phorbol diester and formyl peptide: synergistic augmentation by interferon-gamma and tumor necrosis factor.
    Yoshie O; Majima T; Saito H
    J Leukoc Biol; 1989 Jan; 45(1):10-20. PubMed ID: 2536064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of antiviral actions of TNF and IFN-gamma: evidence for a major role of TNF-induced IFN-beta.
    Hughes TK; Kaspar TA; Coppenhaver DH
    Antiviral Res; 1988 Nov; 10(1-3):1-9. PubMed ID: 2852914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.
    Aggarwal BB; Eessalu TE; Hass PE
    Nature; 1985 Dec 19-1986 Jan 1; 318(6047):665-7. PubMed ID: 3001529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
    Shirazi Y; Pitha PM
    J Hum Virol; 1998; 1(2):69-76. PubMed ID: 10195234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of miR‑122 expression affects the interferon response in human hepatoma cells.
    Li A; Qian J; He J; Zhang Q; Zhai A; Song W; Li Y; Ling H; Zhong Z; Zhang F
    Mol Med Rep; 2013 Feb; 7(2):585-90. PubMed ID: 23241652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha.
    Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M
    Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma.
    Carrel S; Hartmann F; Salvi S; Albrecht H; Schreyer M; Rimoldi D
    Int J Cancer; 1995 Jul; 62(1):76-83. PubMed ID: 7601571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.